Related Experiment Video
Updated: Jul 8, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Antileukemic activity of genistein, a major isoflavone present in soy products
Noël J-M Raynal1, Louise Momparler, Michel Charbonneau
1INRS-Institut Armand-Frappier, Université du Québec, Laval, Canada.
Abstract:
Soy has been used in traditional medicine for the treatment of various diseases, including cancer. The isoflavones present in soy have been shown in animal models to have cancer-preventing activity. However, the therapeutic effects of isoflavones against cancer are still unclear. We have evaluated the in vitro and in vivo antileukemic activity of genistein (1), a major isoflavone present in soy. We observed that it produced a dose- and time-dependent antineoplastic activity against myeloid and lymphoid leukemic cell lines. In addition, genistein treatment of the leukemic cells reactivated tumor suppressor genes that were silenced by aberrant DNA methylation. A genistein-enriched diet produced a moderate, but significant, antileukemic effect in mice. The limited extent of this in vivo response may have been due to the rapid metabolic inactivation of genistein in mice. Due to the longer half-life of genistein in humans, a soy-enriched diet has the potential to produce plasma levels of this isoflavone in the range of the concentrations used in vitro that produced an antileukemic activity.
Insights
Soy isoflavones, like genistein, show potential in fighting leukemia by reactivating tumor suppressor genes. A soy-rich diet may offer therapeutic benefits due to genistein
Area of Science:
- Biochemistry
- Oncology
- Nutritional Science
Background:
- Soy and its isoflavones have historical use in traditional medicine for various diseases, including cancer.
- While animal models suggest cancer-preventing activity of soy isoflavones, their direct therapeutic effects against cancer remain under investigation.
Purpose of the Study:
- To evaluate the in vitro and in vivo antileukemic activity of genistein, a primary soy isoflavone.
- To investigate the mechanism of genistein's action, specifically its effect on tumor suppressor gene methylation in leukemic cells.
Main Methods:
- In vitro assessment of genistein's antineoplastic effects on myeloid and lymphoid leukemic cell lines.
- In vivo study using a genistein-enriched diet in mice to assess antileukemic effects.
- Analysis of DNA methylation patterns and tumor suppressor gene reactivation following genistein treatment.
Main Results:
- Genistein demonstrated dose- and time-dependent antineoplastic activity against leukemic cell lines in vitro.
- Genistein treatment reactivated silenced tumor suppressor genes by reversing aberrant DNA methylation.
- A genistein-enriched diet induced a moderate but significant antileukemic effect in mice.
Conclusions:
- Genistein exhibits significant antileukemic properties, acting through the reactivation of tumor suppressor genes.
- The rapid metabolic inactivation of genistein in mice may limit its in vivo efficacy.
- Given its longer half-life in humans, a soy-enriched diet could achieve therapeutic genistein plasma levels for potential antileukemic activity.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Cancer Prevention
Some...
Inhibitors of Viral Protein Synthesis

